Dr. Bunn on the Response of Immunotherapy in Lung Cancer

Paul A. Bunn Jr, MD
Published: Wednesday, Sep 06, 2017



Paul A. Bunn Jr, MD, distinguished professor, Division of Medical Oncology/University of Colorado, James Dudley Chair in Lung Cancer Research, University of Colorado Denver, 2014 Giant of Cancer Care in Lung Cancer, discusses the response of immunotherapy in patients with lung cancer.

Patients with stable disease may have a true pathologic response to immunotherapy. If the patient seems to benefitting, they can stop receiving treatment and repeat the CT scan, explains Bunn.
 


Paul A. Bunn Jr, MD, distinguished professor, Division of Medical Oncology/University of Colorado, James Dudley Chair in Lung Cancer Research, University of Colorado Denver, 2014 Giant of Cancer Care in Lung Cancer, discusses the response of immunotherapy in patients with lung cancer.

Patients with stable disease may have a true pathologic response to immunotherapy. If the patient seems to benefitting, they can stop receiving treatment and repeat the CT scan, explains Bunn.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Leveraging Liquid Biopsies in Tumor Characterization for NSCLC TherapyJan 31, 20181.5
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Publication Bottom Border
Border Publication
x